The evolving role of targeted metformin administration for the prevention and treatment of endometrial cancer: A systematic review and meta-analysis of randomized controlled trials

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492 Lortet-Tieulent, 2018, International patterns and trends in endometrial cancer incidence, 1978-2013, J Natl Cancer Inst, 110, 354, 10.1093/jnci/djx214 Siegel, 2020, Cancer statistics, 2020, CA Cancer J Clin, 70, 7, 10.3322/caac.21590 Colombo, 2016, ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up, Ann Oncol, 27, 16, 10.1093/annonc/mdv484 Takiuchi, 2018, Aspirin use and endometrial cancer risk and survival, Gynecol Oncol, 148, 222, 10.1016/j.ygyno.2017.10.026 Zhang, 2016, Can aspirin reduce the risk of endometrial cancer?: a systematic review and meta-analysis of observational studies, Int J Gynecol Cancer, 26, 1111, 10.1097/IGC.0000000000000731 Kim, 2019, Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth, Gynecol Oncol, 154, 432, 10.1016/j.ygyno.2019.05.022 Feng, 2016, Statin use significantly improves overall survival in high-grade endometrial cancer, Int J Gynecol Cancer, 26, 1642, 10.1097/IGC.0000000000000819 Chu, 2018, Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis, BMC Cancer, 18, 438, 10.1186/s12885-018-4334-5 Nevadunsky, 2014, Metformin use and endometrial cancer survival, Gynecol Oncol, 132, 236, 10.1016/j.ygyno.2013.10.026 Meireles, 2017, Effects of metformin on endometrial cancer: systematic review and meta-analysis, Gynecol Oncol, 147, 167, 10.1016/j.ygyno.2017.07.120 Mitsuhashi, 2019, Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients, J Gynecol Oncol, 30, e90, 10.3802/jgo.2019.30.e90 Liu, 2017, Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: a systematic review and meta-analysis, Oncotarget, 8, 16017, 10.18632/oncotarget.13762 Wang, 2014, Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis, Diabetes Res Clin Practice, 106, 19, 10.1016/j.diabres.2014.04.007 Zhu, 2015, Metformin and lung cancer risk of patients with type 2 diabetes mellitus: a meta-analysis, Biomed Rep, 3, 235, 10.3892/br.2015.417 Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration, Bmj, 339, 10.1136/bmj.b2700 Higgins, 2011, The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, Bmj, 343, 10.1136/bmj.d5928 DerSimonian, 2007, Random-effects model for meta-analysis of clinical trials: an update, Contemp Clin Trials, 28, 105, 10.1016/j.cct.2006.04.004 Hozo, 2005, Estimating the mean and variance from the median, range, and the size of a sample, BMC Med Res Methodol, 5, 13, 10.1186/1471-2288-5-13 Acosta-Torres S., Murdock T., Matsuno R., et al. The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: little impact on response and low live-birth rates. Gynecol Oncol 2020. Sivalingam, 2016, Measuring the biological effect of presurgical metformin treatment in endometrial cancer, Br J Cancer, 114, 281, 10.1038/bjc.2015.453 Tabrizi, 2014, Antiproliferative effect of metformin on the endometrium–a clinical trial, Asian Pac J Cancer Prev, 15, 10067, 10.7314/APJCP.2014.15.23.10067 Sharifzadeh, 2017, A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia, Gynecol Endocrinol, 33, 152, 10.1080/09513590.2016.1223285 Kitson, 2019, PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial, Clin Cancer Res, 25, 2424, 10.1158/1078-0432.CCR-18-3339 Petchsila, 2020, Effect of metformin for decreasing proliferative marker in women with endometrial cancer: a randomized double-blind placebo-controlled trial, Asian Pac J Cancer Prev, 21, 733, 10.31557/APJCP.2020.21.3.733 Shan, 2014, Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia, J Gynecol Oncol, 25, 214, 10.3802/jgo.2014.25.3.214 Yates, 2018, Prospective randomized biomarker study of metformin and lifestyle intervention for prevention in obese women at increased risk for endometrial cancer, Cancer Prev Res (Phila), 11, 477, 10.1158/1940-6207.CAPR-17-0398 Davis, 2018, The benefits of adding metformin to tamoxifen to protect the endometrium-A randomized placebo-controlled trial, Clin Endocrinol (Oxf), 89, 605, 10.1111/cen.13830 Yang, 2020, Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial, Bjog, 127, 848, 10.1111/1471-0528.16108 Kim, 2015, Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes, Breast Cancer Res, 17, 64, 10.1186/s13058-015-0574-3 Mei, 2014, Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis, PLoS ONE, 9, e91818, 10.1371/journal.pone.0091818 Pimentel, 2019, A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy, Breast, 48, 17, 10.1016/j.breast.2019.08.003 Wen, 2019, The association between metformin therapy and risk of gynecological cancer in patients: two meta-analyses, Eur J Obstetr Gynecol Reproduct Biol, 237, 33, 10.1016/j.ejogrb.2019.03.029 Mitsuhashi, 2016, Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer, Ann Oncol, 27, 262, 10.1093/annonc/mdv539 Soliman, 2020, Everolimus, letrozole, and metformin in women with advanced or recurrent endometrioid endometrial cancer: a multi-center, single arm, phase ii study, Clin Cancer Res, 26, 581, 10.1158/1078-0432.CCR-19-0471